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Abstract
Background: Cornelia de Lange syndrome is the prototype for cohesinopathy disorders, which are characterized
by defects in chromosome segregation. Kidney malformations, including nephrogenic rests, are common in
Cornelia de Lange syndrome. Only one post-mortem case report has described an association between Wilms
tumor and Cornelia de Lange syndrome. Here, we describe the first case of a living child with both diseases.
Case presentation: Non-anaplastic triphasic nephroblastoma was diagnosed in a patient carrying a not yet
reported mutation in NIPBL (c.4920 G > A). The patient had the typical facial appearance and intellectual disability
associated with Cornelia de Lange syndrome in absence of limb involvement. The child’s kidneys were examined
by ultrasound at 2 years of age to exclude kidney abnormalities associated with the syndrome. She underwent
pre-operative chemotherapy and nephrectomy. Seven months later she was healthy and without residual
detectable disease.
Conclusion: The previous report of such co-occurrence, together with our report and previous reports of nephrogenic
rests, led us to wonder if there may be any causal relationship between these two rare entities. The wingless/integrated
(Wnt) pathway, which is implicated in kidney development, is constitutively activated in approximately 15–20 % of all
non-anaplastic Wilms tumors. Interestingly, the Wnt pathway was recently found to be perturbed in a zebrafish model of
Cornelia de Lange syndrome. Mutations in cohesin complex genes and regulators have also been identified in several
types of cancers. On the other hand, there is no clear evidence of an increased risk of cancer in Cornelia de Lange
syndrome, and no other similar cases have been published since the fist one reported by Cohen, and this prompts to
think Wilms tumor and Cornelia de Lange syndrome occurred together in our patient by chance.
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Background
Cornelia de Lange syndrome (CdLS, OMIM 608667) is
the prototype for cohesinopathy disorders, which are
developmental disorders with mutations in an evolution-
arily conserved complex that functions in sister chroma-
tin cohesion. However, the complex is also implicated in
an increasing number of functions, including transcrip-
tion regulation, DNA repair, chromosome condensation,
and homolog pairing [1]. The CdLS phenotype is widely
heterogeneous but characterized mainly by distinctive fa-
cial features, growth and cognitive retardation, limb de-
fects, and a range of other malformations of the heart
and kidney, among others [2]. Approximately 60 % of
CdLS patients have mutations in NIPBL [3–6], and ap-
proximately 5 % have mutations in one of the other
cohesin-associated genes, including SMC1A, SMC3,
HDAC8, and RAD21 [7–10]. Almost all of these muta-
tions are de novo.
Genotype-phenotype correlations have been reported
for these CdLS-associated mutations. For example,
NIPBL mutations are typically found in patients with
classical CdLS features, with missense mutations giving
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rise to milder phenotypes. In contrast, mutations in
SMC1A or SMC3 are associated with fewer structural
anomalies and consistently with intellectual disability.
Mutations in HDAC8 and RAD21 are now recognized as
being associated with milder phenotypes without limb
involvement and with atypical phenotypes with milder
cognitive involvement and typical facial features [11–13].
Increased knowledge about the genetic basis of CdLS
has led to an expansion of the phenotype and specula-
tion that the prevalence of CdLS, first estimated to be
1.24/100,000 births, may actually be higher (~1/10,000).
CdLS is commonly associated with a wide range of
renal abnormalities [2, 14], including nephrogenic
rests [15, 16]. To the best of our knowledge, only one
case of Wilms tumor (WT) and CdLS has been re-
ported in the literature. The case was a post-mortem
finding in a girl who died of bronchopneumonia at
7 months of age [17]. Here, we report a second case of
the co-occurrence of WT and CdLS in a 3-year-old
girl, the first in a living child. The tumor was detected
by ultrasound examination at the age of 2 years that
was performed as part of a routine exam because of
the CdLS syndrome. This co-occurrence prompted us
to question whether CdLS could have predisposed the
patient to developing WT or whether the two entities
co-occurred by chance.
Case presentation
The patient, a 4-year-old girl, was the second child of a
healthy, nonconsanguineous couple. The family history
was negative for genetic diseases, and the child was born
after a normal gestation by vaginal delivery. Her birth
weight was 2.600 g (5th percentile), her length was 47 cm
(10th percentile), and her occipitofrontal circumference
(OFC) was 30.5 cm (<3rd percentile). The following fea-
tures were noted at birth: a high palate, synophrys, low-set
hairline, a small up-turned nose, a single transverse pal-
mar crease, and hypertrichosis of the face and the back.
No major hand malformations were detected, and an
examination of the kidneys and urinary tract showed no
anomalies. The phenotype was mild (total score 14) ac-
cording to the clinical score suggested by Selicorni et al.
[6]. The standard karyotype was normal. A suspicion of
CdLS was confirmed by molecular analysis of NIPBL
(NM_133433), which revealed a c.4920 G > A de novo mu-
tation. This variant has never been reported in the litera-
ture, ExaC, or the 1000 Genomes browser. The variant is
considered disease-causing by prediction tools (i.e., mu-
tation tester) with a high probability score. A perturb-
ation of normal splicing is expected, in fact the
mutation affects the last base of exon 24. Moreover, the
variant was not present in the patient’s parents, con-
firming its pathogeneticity. A hyperechoic solid mass in
the right kidney measuring approximately 3 cm at its
maximum diameter was detected by renal ultrasound
scan performed as part of a routine exam at the age of
2 years. The lesion lacked MRI contrast enhancement
and initially thought to be benign. However, one year
later, ultrasound showed that the mass had grown to a
length of 5 cm. Computerized tomography (CT) char-
acterized the lesion as a large enhanced mass protrud-
ing from the renal capsule that did not affect vessels
or adipose tissue; these findings suggested that the le-
sion had a malignant nature. A Tru-Cut biopsy re-
vealed non-anaplastic triphasic nephroblastoma, and
the patient was treated pre-operatively according to
the AIEOP-TW-2003 protocol (i.e., four courses of a
regimen of vincristine and actinomycin D). Nephrec-
tomy was then performed, followed by an additional
4 weeks of chemotherapy. At the last follow-up
19 months after treatment, the patient was healthy
with no detectable disease, with hypertrophy of the
contralateral kidney, 75th percentile according to body
surface area (BSA), and a normal glomerular filtration
rate (128 mL/min/1.73 m2 BSA). At that time, the pa-
tient’s weight was 11.5 kg (50th percentile for CdLS),
height 92 cm (50th percentile for CdLS), and OFC
42 cm (50th percentile for CdLS) [18].
Conclusion
Kidney malformations are commonly seen in CdLS.
Selicorni et al. [14] reported a 41 % global incidence of
renal abnormalities in pediatric CdLS patients. Al-
though some evidence indicates premature aging in
CdLS patients and mutations in cohesin complex
genes and regulators have been identified in several
types of cancers, the incidence of malignancy does not
seem to be increased in CdLS patients compared to
the general population [19, 20].
There are only single reports of different type of tumors
co-occurring with CdLS, including suprasellar germinoma
[21], papilloma of the chorioid [22], adenocarcinoma of
the esophagus [23], hemangioendothelioma, and WT [17].
The last two were incidental findings at autopsy. The WT
seemed to have been non-anaplastic on the basis of the
microscopic histological description. The majority of these
tumors (i.e., germinoma, hemangioendothelioma, WT)
typically occur in childhood. The cohesin network is in-
volved in gene expression during embryogenesis, and the
CdLS phenotype clearly reflects the effects of cohesin
network disruption on the embryogenesis of various or-
gans and tissues.
Wilms Tumor, or nephroblastoma, is the most com-
mon renal tumor in childhood. In 1988–1997, the age-
standardized incidence rate of childhood renal tumors in
Europe was 8.8 per million, with WT accounting for
93 % of cases [24]. Several genetic syndromes are related
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to a specific, and sometimes quantified, increased risk of
WT, but the extreme rarity of the co-occurrence of WT
with particular syndromes makes it difficult to establish
a direct relationship between the two [25, 26]. This may
also be the case for CdLS and WT.
The disruption of at least three genetic pathways has
been linked to tumorigenesis in WTs, partially explaining
its heterogeneity [27]. The wingless/integrated (Wnt)/β-
catenin pathway (canonical Wnt pathway) [28–31] is
constitutively activated in approximately 15–20 % of all
non-anaplastic WTs; abrogation of the pathway can pro-
mote tumorigenesis and nephrogenic rest development
[32]. WNT and related signaling pathways also play a cru-
cial role in kidney differentiation and the initiation of
nephrogenesis [27].
Pistocchi et al. [33] examined the effects of perturba-
tions in the canonical WNT pathway in a zebrafish
model of CdLS with a focus on its expression in the
developing central nervous system. These experiments
suggested that the WNT pathway is downregulated by a
loss-of-function of NIPBL. The interaction between
cohesin and WNT pathways is of great interest because
WNT plays a role in the non-anaplastic forms of WT,
which is the histological type in the patient reported
here. Unfortunately, we could not retrieve the biopsied
tissue.
To the best of our knowledge, this is the second
report of WT associated with CdLS and the first report
in a living patient. We explored whether the co-
occurrence is stochastic or represents one possible
scenario of kidney involvement due to CdLS. The lat-
ter hypothesis may be supported by the known role of the
cohesin network in embryogenesis and by some reports of
nephrogenic rests in CdLS [16]. Notably, nephrogenic
rests are considered potential direct precursors of WT
[34]. These observations led also to the hypothesis that
WT tumorigenesis results from postnatal retention and
dysregulated differentiation of blastemal elements in the
kidney. Finally, a potential association between CdLS and
WT may be underestimated because of spontaneous WT
resolution, a misdiagnosis of nephrogenic rests, or a
milder misdiagnosed CdLS phenotype. However, no
other similar reports have been published in recent de-
cades, and nephrogenic rests are found in 1 % of unse-
lected pediatric autopsies [35, 36]. This rather prompts
to think WT and CdLS occurred together by chance.
In conclusion, we reported the unusual co-occurrence
of CdLS and WT, raising questions about an increased
risk of WT development in patients with CdLS. Larger
population studies are needed. To the best of our know-
ledge, WT has not been reported in cohesinopathies other
than CdLS. Ultrasound screening during childhood is still
indicated in CdLS because of the high prevalence of uro-
genital anomalies.
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